AstraZeneca Breztri met primary endpoints in Phase III trials in asthma Ruchika Sharma4 May 2025 10:30 AM ISTAstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that...
Early Intratracheal Budesonide Treatment Has Minimal Effect on BPD-Free Survival in Preterm Infants: PLUSS Trial Medha Baranwal19 Nov 2024 8:30 PM ISTAustralia: In extremely preterm infants treated with surfactant for respiratory distress syndrome, early administration of intratracheal budesonide...
Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA Farhat Nasim19 Nov 2024 6:19 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...
AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Include nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on Pulmonary FDC Dr. Divya Colin14 Jun 2024 6:00 PM ISTNew Delhi: Citing to include nebulization methodology, type of nebulizer, and interface, the Subject Expert Committee (SEC) functional under the...
Budesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real world study Dr. Shravani Dali7 Jun 2024 8:30 PM ISTBudesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real-world study suggests a study published in the International...
NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation Dr. Divya Colin2 Jun 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Department of...
Not approved as Inhalation suspension for nebulization, Conduct CT: CDSCO Panel Tells Glenmark on Pulmonary FDC Dr. Divya Colin2 April 2024 6:00 PM ISTNew Delhi: Noting that the proposed fixed-dose combination (FDC) of Glycopyrrolate plus Formoterol Fumarate Dihydrate plus Budesonide (25mcg+20mcg+500...
AstraZeneca Pharma India, Mankind Pharma collaborate to distribute asthma medicine Symbicort in India Ruchika Sharma13 March 2024 2:30 PM ISTBangalore: AstraZeneca Pharma India Limited and Mankind Pharma Limited have entered into an agreement for exclusive distribution of AstraZeneca’s...
COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol Ruchika Sharma15 Dec 2023 4:30 PM ISTBangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO)...
Show lung deposition of triple drug combination in Inhalation Suspension: CDSCO Panel tells Glenmark on Pulmonary FDC Drug Dr. Divya Colin2 Nov 2023 5:37 PM ISTNew Delhi: In line with the proposal presented by the drug major Glenmark Pharmaceuticals for the bioequivalence (BE) and Phase III clinical trial...
CDSCO panel tells Glenmark to provide in-vivo data, global data concerning Pulmonary FDC in inhalation suspension Roshni Dhar1 Oct 2023 3:15 PM ISTIn reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary drug...
